| Name | Title | Contact Details |
|---|
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Want to sell your vet hospital? We are a veterinarian-owned and managed network of animal hospitals for veterinarians who wish to sell their veterinary practice. Offering veterinary career opportunities. Call 205-453-4760 today!
Claflin Canada is a Niagara Falls, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Careington International Corp is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Frisco, TX. To find more information about Careington International Corp, please visit www.careington.com
Camarillo Health Care District is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Camarillo, CA. To find more information about Camarillo Health Care District, please visit www.camhealth.com